DIA 48th Annual Meeting
Click here to go to the previous page
Biomarker Focused Strategies for Personalized Medicine
Track : Track 04: Nonclinical and Translational Development/Early Phase Clinical Development
Program Code: 378
Date: Wednesday, June 27, 2012
Time: 3:30 PM to 5:00 PM  EST
CHAIR :
Renee Pridgen, Duke Clinical Research Institute, United States
PRESENTER (S):
 Kenneth Pennline, Labcorp Clinical Trials, United States
Deepak Voora, Duke Institute for Genome Sciences and Policy, United States
 E. David Litwack, National Institute of Health, United States
Description
Clinical care centers on standards based on epidemiological studies of large cohorts. However, these studies do not take into account genetic variability. This session discusses the pursuit of personalized medicine through biomarker collection.

Learning Objectives:
Describe the importance of incorporating biomarker collection into clinical trials in the pursuit of developing a more personalized approach to medicine and clinical care
Distinguish the "omics" of biomarkers (proteomics, genomics, transcriptomics, metabolomics).